Insulet (NASDAQ: PODD) reported Q4 EPS of ($0.16), $0.11 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $103.6 million versus the consensus estimate of $100.61 million.

GUIDANCE:

Insulet sees FY2017 revenue of $420-440 million.

For earnings history and earnings-related data on Insulet (PODD) click here.